Johnson & Johnson and Bayer HealthCare Seek Added Use for Xarelto

Johnson & Johnson said it has asked regulators to approve its anticlotting drug Xarelto as a treatment for blood clots in the legs that can travel to a patient's lungs. The company said today it f…
Read the full story: BioSpace.com Featured News